Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-07-19

Clinical Trial Update: Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update comparing Clopidogrel-Aspirin therapy versus Apixaban-Aspirin therapy after lower limb revascularization (Phase 1/Phase 2; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban Aspirin Therapy (apixaban)
  • Clopidogrel Aspirin Therapy (clopidogrel)

Snippet

Sponsor: Mansoura University | Conditions: Ischemia, Anticoagulants | Phase 1, Phase 2 | Status: COMPLETED